Last 343.95 INR
Change Today -9.75 / -2.76%
Volume 301.4K
ALPM On Other Exchanges
Symbol
Exchange
Natl India
As of 5:15 AM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

alembic pharmaceuticals ltd (ALPM) Snapshot

Open
355.00
Previous Close
353.70
Day High
365.30
Day Low
340.00
52 Week High
07/22/14 - 370.70
52 Week Low
08/21/13 - 120.30
Market Cap
64.8B
Average Volume 10 Days
359.8K
EPS TTM
12.49
Shares Outstanding
188.5M
EX-Date
07/17/14
P/E TM
27.5x
Dividend
3.00
Dividend Yield
0.87%
Current Stock Chart for ALEMBIC PHARMACEUTICALS LTD (ALPM)

Related News

No related news articles were found.

alembic pharmaceuticals ltd (ALPM) Related Businessweek News

No Related Businessweek News Found

alembic pharmaceuticals ltd (ALPM) Details

Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and Intermediates in India and internationally. The company operates in three segments: International Generics, Branded Formulations, and Active Pharmaceutical Ingredients. It offers active pharmaceutical ingredients for anti-infective, cardio-vascular, musculoskeletal, erectile dysfunction, and gastro-intestinal products. The company also provides bulk pharma chemicals, including phosgene gas and phosgene based specialty chemicals/intermediates for use in pesticides, pharmaceuticals, dyes, plastics, perfumeries, etc.; and drug intermediates, specialty chemicals, and fine chemicals, as well as is engaged in contract manufacturing and custom synthesis activities. In addition, it offers finished dosage formulations for various therapeutic areas, including anti-infective, cough and cold, cardiovascular, and oral anti-diabetics; herbal nutraceuticals; veterinary products; and contract/collaborated research services. The company was founded in 1907 and is headquartered in Vadodara, India.

Founded in 1907

alembic pharmaceuticals ltd (ALPM) Top Compensated Officers

Chairman and Managing Director
Total Annual Compensation: 30.0M
President-Finance, Compliance Officer, Compan...
Total Annual Compensation: 19.5M
President of International Business, Executiv...
Total Annual Compensation: 34.6M
President of Branded Formulations Business an...
Total Annual Compensation: 33.8M
Compensation as of Fiscal Year 2014.

alembic pharmaceuticals ltd (ALPM) Key Developments

Alembic Pharmaceuticals Limited Proposes Amendment to its Articles of Association

Alembic Pharmaceuticals Limited proposed amendment to its Articles of Association, at the AGM to be held on July 28, 2014.

Alembic Pharmaceuticals Limited Announces Consolidated Financial Results for the Fourth Quarter and Year Ended March 31, 2014

Alembic Pharmaceuticals Limited announced consolidated financial results for the fourth quarter and year ended March 31, 2014. For the quarter, the company reported net sales up by 23% to INR 4,652 million against INR 3,784 million in the corresponding quarter last year. Profit before tax up by 46% to INR 808 million against INR 552 million in the corresponding quarter last year. Net profit after tax up by 40% to INR 613 million against INR 437 million in the corresponding quarter last year EBITDA margins is 19.6% at INR 913 million against 17.3% at INR 656 million in the corresponding quarter last year. Operating income was INR 91,290 million compared with INR 65,580 million for the same period a year ago. For the year, the company reported net sales up by 22% to INR 18,684 million against INR 15,260 million last year. Profit before tax up by 51% to INR 3,106 million against INR 2,064 million last year. Net profit after tax up by 43% to INR 2,355 million against INR 1,653 million last year. EBITDA margins is 19.2% at INR 3,577 million against 16.5% at INR 2,520 million last year. Operating income was INR 357,710 million compared with INR 251,960 million for the same period a year ago.

Alembic Pharmaceuticals Limited Recommends Dividend

Alembic Pharmaceuticals Limited announced that the Board of Directors of the company at its meeting held on April 28, 2014 has recommended a dividend of INR 3.00 (150%) per Equity Share of INR 2 each, subject to approval of Shareholders at the Annual General Meeting.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALPM:IN 343.95 INR -9.75

ALPM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ALPM.
View Industry Companies
 

Industry Analysis

ALPM

Industry Average

Valuation ALPM Industry Range
Price/Earnings 27.8x
Price/Sales 3.5x
Price/Book 9.7x
Price/Cash Flow 23.8x
TEV/Sales 3.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEMBIC PHARMACEUTICALS LTD, please visit www.alembic-india.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.